COLLEGIUM PHARMACEUTICAL INC's ticker is and the CUSIP is 19459JAA2. A total of 17 filers reported holding COLLEGIUM PHARMACEUTICAL INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $30,799 | +1.9% | 30,000 | 0.0% | 0.01% | +10.0% |
| Q2 2023 | $30,237 | -5.5% | 30,000 | 0.0% | 0.01% | -16.7% |
| Q1 2023 | $31,990 | +5.5% | 30,000 | 0.0% | 0.01% | 0.0% |
| Q4 2022 | $30,308 | +21.2% | 30,000 | 0.0% | 0.01% | +9.1% |
| Q3 2022 | $25,000 | -3.8% | 30,000 | 0.0% | 0.01% | +10.0% |
| Q2 2022 | $26,000 | – | 30,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 17,500,000 | $189,560,000 | 2.40% |
| STEELHEAD PARTNERS LLC | 21,000,000 | $22,877,000 | 1.73% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 30,245,000 | $33,292,000 | 1.33% |
| DeepCurrents Investment Group LLC | 8,900,000 | $9,745,000 | 0.34% |
| LINDEN ADVISORS LP | 28,000,000 | $30,455,000 | 0.23% |
| Teton Advisors, Inc. | 500,000 | $542,000 | 0.08% |
| Verition Fund Management LLC | 2,589,000 | $2,823,000 | 0.03% |
| GABELLI & Co INVESTMENT ADVISERS, INC. | 190,000 | $206,000 | 0.03% |
| LAZARD ASSET MANAGEMENT LLC | 18,000,000 | $19,628,000 | 0.02% |
| GABELLI FUNDS LLC | 3,000,000 | $3,254,000 | 0.02% |